Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Panbela Therapeutics Inc (NQ: PBLA )

6.990 -0.140 (-1.96%)
Streaming Delayed Price Updated: 9:57 AM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,699
Open 7.140
Bid (Size) 6.980 (5)
Ask (Size) 7.150 (3)
Prev. Close 7.130
Today's Range 6.990 - 7.140
52wk Range 0.2100 - 58.00
Shares Outstanding 16,786,821
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 69 stocks hit new 52-week lows. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start the week off right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning! 
Via InvestorPlace

Performance

YTD
+113.11%
+113.11%
1 Month
+1669.62%
+1669.62%
3 Month
+928.55%
+928.55%
6 Month
+81.28%
+81.28%
1 Year
-87.15%
-87.15%

More News

Read More
Panbela Therapeutics: Q1 Earnings Insights
Via Benzinga
Panbela Announces Poster Presentation at Immunology of Diabetes Society Meeting: Evaluating the Potential of CPP-1X (Eflornithine) in Recent Onset Type 1 Diabetes
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Crude Oil Down 2%; Donaldson Shares Drop Following Q3 Results
Via Benzinga
Nasdaq Down 100 Points; Advance Auto Parts Earnings Miss Views
Via Benzinga
Panbela Announces 1-for-30 Reverse Stock Split Effective June 1, 2023
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Why Capri Holdings Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Panbela Announces Clinical Trial with Moffitt Cancer Center for Phase I/II Program in STK11 Mutant Non-Small Cell Lung Cancer
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why ClearOne Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Panbela's Game Changer: Analyst Bets Big on Promising Pancreatic Cancer Combatant
Via Benzinga
Crude Oil Down 3%; Boeing Reports Better-Than-Expected Sales
Via Benzinga
Dow Edges Lower; Alphabet Posts Upbeat Results
Via Benzinga
Why Chipotle Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 26, 2023
Via Benzinga
Panbela to Host First Quarter 2023 Earnings Conference Call on May 4, 2023
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Panbela Announces Poster Presentation at American Association for Cancer Research: Evaluating the potential of spermine analogue ivospemin (SBP-101) in combination with chemotherapy in ovarian cancer
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Why Sonnet BioTherapeutics Shares Are Trading Lower By Around 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Navidea Biopharmaceuticals Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Teva Pharmaceutical Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Panbela Therapeutics Shares Are Trading Higher Today
Via Benzinga
Why Panbela Therapeutics Shares Are Trading Higher By Around 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.